Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1681
    +0.0024 (+0.21%)
     
  • GBP/USD

    1.2493
    -0.0018 (-0.15%)
     
  • Bitcoin GBP

    51,220.13
    -475.96 (-0.92%)
     
  • CMC Crypto 200

    1,331.62
    -64.92 (-4.65%)
     
  • S&P 500

    5,107.83
    +59.41 (+1.18%)
     
  • DOW

    38,316.19
    +230.39 (+0.60%)
     
  • CRUDE OIL

    83.84
    +0.27 (+0.32%)
     
  • GOLD FUTURES

    2,350.70
    +8.20 (+0.35%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

How I Pick Approved Needles in a Vaccine Haystack

How I Pick Approved Needles in a Vaccine Haystack

In the last few weeks, bio-tech companies of all sizes have made impressive strides toward a vaccine. Many dozens of approaches are being taken, most will fail. With a future potential coronavirus inoculation carrying such an overwhelmingly positive public utility, which company will win? Choosing from the companies racing to the finish line is quite difficult, and also risky.